Effect of Lentinula edodes (Shiitake mushroom) for allergic rhinitis and atopic dermatitis

Effect of Lentinula edodes (Shiitake mushroom) for allergic rhinitis and atopic dermatitis - Effect of Lentinula edodes (Shiitake mushroom) for allergic rhinitis and atopic dermatitis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011196

Enrollment

120

Registered

2013-07-16

Start date

2013-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis, atopic dermatitis

Interventions

Groups 1

no administration, Duration: 4 weeks Dose: Non Times: 1 time/day Groups 2

shiitake chips A, Duration: 4 weeks Dose: Chips 3 gram Times: 1 time/day Groups 3

shiitake chips B Duration: 4 weeks Dose: Chips 3 gram Times: 1 time/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: allergic rhinitis or atopic dermatitis diagnosed by each specialists

Exclusion criteria

Exclusion criteria: Patients judged inappropriate for this study by the physicians

Design outcomes

Primary

Measure	Time frame
Assesment of these diseases before and after (4 weeks after) as below. allergic rhinitis: medical examination at the department of otorhinolaryngology with a disease questionnaire atopic dermatitis: medical examination at the department of dermatology with a disease questionnaire	—

Secondary

Measure	Time frame
serum biomarkers	—

Countries

Japan

Contacts

Public ContactMasaru Yoshida

Kobe University Graduate School of Medicine Division of Metabolomics Research

myoshida@med.kobe-u.ac.jp+81-78-382-6305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026